Estimating the Potential Health Care Cost-Savings from a Flax-Based Treatment for Hypertension

Area of Science:

• Cardiovascular Health
• Health Economics
• Nutritional Science

Background:

• Hypertension is a major driver of Canadian healthcare expenditure due to direct medical costs and its role as a risk factor for other chronic diseases.
• Reducing hypertension prevalence is crucial for alleviating the financial burden on the Canadian healthcare system.
• Flaxseed consumption has been clinically shown to lower both systolic and diastolic blood pressure.

Purpose of the Study:

• To estimate the potential healthcare cost-savings in Canada attributable to a flaxseed-based hypertension treatment.
• To analyze the economic impact of reduced hypertension prevalence through dietary intervention.

Main Methods:

• A four-step cost-of-illness analysis was employed.
• The study assessed the likely adoption rate of flaxseed regimen, its impact on blood pressure, and estimated hypertension prevalence reduction using Canadian Health Measures Survey data.
• Sensitivity analyses and Monte Carlo simulations were used to account for uncertainties in parameters like intake success rate.

Main Results:

• The analysis projected potential healthcare cost-savings in Canada for the year 2020.
• The most conservative estimate indicated potential savings of CAD 96,284,344.
• The study quantified the economic benefits of integrating flaxseed into hypertension management.

Conclusions:

• Flaxseed consumption presents a viable strategy for reducing hypertension prevalence and its associated economic burden in Canada.
• Implementing flaxseed-based interventions could lead to substantial savings within the Canadian healthcare system.
• Further research into large-scale adoption and long-term effects is warranted to fully realize these economic benefits.